Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-013052
Filing Date
2019-04-25
Accepted
2019-04-25 16:15:23
Documents
6
Period of Report
2019-06-11
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A eq-def14a_20190430.htm DEF 14A 608368
2 GRAPHIC g2pq30dv0flp000003.jpg GRAPHIC 3107
3 GRAPHIC g2pq30dv0flp000005.jpg GRAPHIC 64128
4 GRAPHIC g2pq30dv0flp000001.jpg GRAPHIC 1807
5 GRAPHIC g2pq30dv0flp000002.jpg GRAPHIC 3107
6 GRAPHIC g2pq30dv0flp000004.jpg GRAPHIC 71340
  Complete submission text file 0001564590-19-013052.txt   807789
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38692 | Film No.: 19767615
SIC: 2834 Pharmaceutical Preparations